Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > and while we are talking about lies

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Sep 25, 2022 4:39pm

98 Views

Post# 34985309

RE:RE:RE:RE:RE:RE:RE:and while we are talking about lies

A $1 million upfront payment is not a look-at-the-smile-on-my-face amount. It goes beyond overpromising. It's downright misleading.

Tickel1st wrote: ..I think we are in for haircuts if this does infact turns out to be an unexpected deal to break all deals.

But I think we still have overpromise and underdeliver again. History is going to repeat itself according to what the market is saying.

Want your money, get your money, keep your money.

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta